FLoRA Replication Atlas › Browse

A SECOND LOOK AT PHARMACEUTICAL SPENDING AS DETERMINANTS OF HEALTH OUTCOMES IN CANADA

G. Emmanuel Guindon, Paul Contoyannis

Health Economics, 2012. DOI 10.1002/hec.1415

Has this study been replicated?

This paper is itself a replication attempt. The study it set out to replicate is listed below.

Study replicated

• Public and private pharmaceutical spending as determinants of health outcomes in Canada, Crémieux et al. (2004). Health Economics. View paper

Cite this record

Emmanuel Guindon, G., & Contoyannis, P. (2012). A SECOND LOOK AT PHARMACEUTICAL SPENDING AS DETERMINANTS OF HEALTH OUTCOMES IN CANADA. Health Economics, 21(12), 1477–1495. Portico. https://doi.org/10.1002/hec.1415

Other studies in the atlas

• Spending on new drug development1
• Ageing of population and health care expenditure: a red herring?
• Ageing and health‐care expenditure: the red herring argument revisited
• The effects of Taiwan's National Health Insurance on access and health status of the…
• THE EFFECT OF TAIWAN'S NATIONAL HEALTH INSURANCE ON MORTALITY OF THE ELDERLY: REVISITED
• Public and private pharmaceutical spending as determinants of health outcomes in Canada

Failed replications · Successful replications · All browse pages